Skip to main content
SpringerLink
Log in

Treatment of Rubeotic Secondary Glaucoma

  • Chapter
Retinal Vascular Disease

Abstract

In most cases (97%) neovascular glaucoma is caused by ischemia [5]. The most common underlying diseases are proliferative diabetic retinopathy and proliferative retinopathy after central retinal vein occlusion (CRVO). Rare types of neovascular glaucoma are of non-ischemic nature (e.g., tumor-induced, inflammatory disease) but should be separated because of different treatment strategies (Table 17.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Akiyama H, Tanaka T, Itakura H, Kanai H, Maeno T, Doi H, Yamazaki M, Takahashi K, Kimura Y, Kishi S, Kurabayashi M (2004) Inhibition of ocular angiogenesis by an adenovirus carrying the human von Hippel-Lindau tumor-suppressor gene in vivo. Invest Ophthalmol Vis Sci 45:1289–96

    Article  PubMed  Google Scholar 

  2. Augustin AJ, D’Amico DJ, Mieler WF, Schneebaum C, Beasley C (2005) Safety of posterior juxtascleral depot administration of the angiostatic cortisone anecortave acetate for treatment of subfoveal choroidal neovascularisation in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 243:9–12

    Article  PubMed  CAS  Google Scholar 

  3. Bartz-Schmidt KU, Thumann G, Psichias A, Krieglstein GK, Heimann H (1999) Pars plana vitrectomy, endolaser coagulation of the retina and the ciliary body combined with silicone oil endotamponade in the treatment of uncontrolled neovascular glaucoma. Graefes Arch Clin Exp Ophthalmol 237:969–75

    Article  PubMed  CAS  Google Scholar 

  4. Central Retinal Vein Occlusion Study Group (1993) Baseline and early natural history report. The Central Retinal Vein Occlusion Study. Arch Ophthalmol 11:1087–95

    Google Scholar 

  5. Brown GC, Magargal LE, Schachat A, Shah H (1984) Neovascular glaucoma. Etiologic considerations. Ophthalmology 91:315–20

    PubMed  CAS  Google Scholar 

  6. Browning DJ (1991) Risk of missing angle neovascularisation by omitting screening gonioscopy in patients with diabetes mellitus. Am J Ophthalmol 112:212

    PubMed  CAS  Google Scholar 

  7. Browning DJ, Scott AQ, Peterson CB, Warnock J, Zhang Z (1998) The risk of missing angle neovascularisation by omitting screening gonioscopy in acute retinal vein occlusion. Ophthalmology 105:776–84

    Article  PubMed  CAS  Google Scholar 

  8. Chalam KV, Gandham S, Gupta S, Tripathi BJ, Tripathi RC (2002) Pars plana modified Baerveldt implant versus neodymium: YAG cyclophotocoagulation in the management of neovascular glaucoma. Ophthalmic Surg Lasers 33:383–393

    PubMed  Google Scholar 

  9. Chen TC, Ahn Yuen SJ, Sangalang MA, Fernando RE, Leuenberger EU (2002) Retrobulbar chlorpromazine injections for the management of blind and seeing painful eyes. J Glaucoma 11:209–13

    Google Scholar 

  10. Custer PL, Reistad CE (2000) Enucleation of blind, painful eyes. Ophthalmic Plast Reconstr Surg 16:326–9

    Article  CAS  Google Scholar 

  11. D’Amico DJ, Goldberg MF, Hudson H, Jerdan JA, Krueger DS, Luna SP, Robertson SM, Russel S, Singerman L, Slakter JS, Yannuzzi L, Zilliox P, Anecortave Acetate Clinical Study Group (2003) Anecortave acetate asmonotherapy for treatment of subfoveal neovascularisation in age-related macular degeneration: twelve-month clinical outcomes. Ophthalmology 110:2372–83

    Article  PubMed  Google Scholar 

  12. De Gottrau P, Holbach LM, Naumann GOH (1994) clinicopathological review of 1146 enucleations (1980–1990). Br J Ophthalmol 78:260–5

    Article  PubMed  Google Scholar 

  13. Eid TE, Katz LJ, Spaeth GL, Augsburger JJ (1997) Tubeshunt surgery versus neodymium:YAG cyclophotocoagulation in themanagement of neovascular glaucoma. Ophthalmology 104:1692–700

    PubMed  CAS  Google Scholar 

  14. Gasch AT, Foster CS, Grosskreutz CL, Paquale LR (2000) Postoperative sympathetic ophthalmia. Int Ophthalmol Clin 40:69–84

    Article  PubMed  CAS  Google Scholar 

  15. Genaidy M, Kazi AA, Peyman GA, Paissos-Machado E, Farahat HG, Williams JI, Holroyd KJ, Blake DA (2002) Effect of squalamine on iris neovascularisation in monkeys. Retina 22:772–8

    Article  PubMed  Google Scholar 

  16. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR, VEGF Inhibition Study in Ocular Neovascularisation Clinical Trial Group (2004) Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351: 2805–16

    Article  PubMed  CAS  Google Scholar 

  17. Han SK, Park Kh, Kim DM, Chang BL (1999) Effect of diode laser trans-scleral cyclophotocoagulation in the management of glaucoma after intravitreal silicone oil injection for complicated retinal detachment. Br J Ophthalmol 83:713–17

    PubMed  CAS  Google Scholar 

  18. Hyang SM, Kim SK (2001) Mid-term effects of trabeculectomy with mitomycin C in neovascular glaucoma patients. Korean J Ophthalmol 15:98–106

    Google Scholar 

  19. Itakura H, Kishim S, Kotajima N, Murakami M (2004) Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy. Ophthalmology 111:1880–4

    Article  PubMed  Google Scholar 

  20. Jonas JB, Hayler JK, Sofker A, Panda-Jonas S (2001) Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone. J Glaucoma 10:284–7

    Article  PubMed  CAS  Google Scholar 

  21. Jonas JB, Degenring RF, Kreissig I, Akkoynun I, Kamppeter BA (2005) Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 112: 593–8

    Article  PubMed  Google Scholar 

  22. Joussen AM, Walter P, Jonescu-Cypers CP, Koizumi K, Poulaki V, Bartz-Schmidt KU, Krieglstein GK, Kirchhof B (2003) Retinectomy for treatment of intractable glaucoma: long term results. Br J Ophthalmol 87:1094–1103

    Article  PubMed  CAS  Google Scholar 

  23. Kuang TM, Liu CJ, Chou CK, Hsu WM(2004) Clinical experience in the management of neovascular glaucoma. J Chin Med Assoc 67:131–5

    PubMed  Google Scholar 

  24. Luttrull JK, Avery RL, Baerveldt G, Easley KA (2000) Initial experience with pneumatically stented Baerveldt implant modified for pars plana insertion for complicated glaucoma. Ophthalmology 107:143–9

    Article  PubMed  CAS  Google Scholar 

  25. Mandal AK, Majji AB, Mandal SP, Das T, Jalali S, Gothwal VK, Jain SS, Nutheti R (2002) Mitomycin-C augmented trabeculectomy for neovascular glaucoma. A preliminary report. Indian J Ophthalmol 50:287–93

    PubMed  Google Scholar 

  26. Martin KR, Broadway DC (2001) Cyclodiode laser therapy for painful, blind glaucomatous eyes. Br J Ophthalmol 85:474–6

    Article  PubMed  CAS  Google Scholar 

  27. Mermoud A, Salmon JF, Alexander P, Straker C, Murray AD (1993) Molteno tube implantation for neovascular glaucoma. Long-term results and factors influencing the outcome. Ophthalmology 100:897–902

    PubMed  CAS  Google Scholar 

  28. Mietz H, Raschka B, Krieglstein GK (1999) Risk factors for failures of trabeculecotomies performed without antimetabolites. Br J Ophthalmol 83:814–21

    Article  PubMed  CAS  Google Scholar 

  29. Mistlberger A, Liebmann JM, Tschiderer H, Ritch R, Ruckhofer J, Grabner G (2001) Diode laser transscleral cyclophotocoagulation for refractory glaucoma. J Glaucoma 10:288–93

    Article  PubMed  CAS  Google Scholar 

  30. Muller VA, Ruokonen P, Schellenbeck M, Hartmann C, Tetz M (2003) Treatment of rubeosis iridis with photodynamic therapy with verteprofin-A new therapeutic and prophylactic option for patients with risk of neovascular glaucoma. Ophthalmic Res 35:60–4

    Article  PubMed  CAS  Google Scholar 

  31. Nabili S, Kirkness CM (2004) Trans-scleral diode laser cyclophoto-coagulation in the treatment of diabetic neovascular glaucoma. Eye 18:352–6

    Article  PubMed  CAS  Google Scholar 

  32. Naumann GD, Portwich E (1976) Ätiologie und Hauptursache für 1000 Enukleationen (Eine klinikopathologische Studie). Klin Monatsbl Augenheilkd 168:622–30

    PubMed  CAS  Google Scholar 

  33. Oguri A, Takahashi E, Tomita G, Yamamoto T, Jikihara S, Kitazawa Y (1998) Transscleral cyclophotocoagulation with the diode laser for neovascular glaucoma. Ophthalmic Surg Lasers 29:722–7

    PubMed  CAS  Google Scholar 

  34. Ohnishi Y, Ishibashi T, Sagawa T (1994) Fluorescein gonioangiography in diabetic neovascularisation. Graefes Arch Clin Exp Ophthalmol 232:199–204

    Article  PubMed  CAS  Google Scholar 

  35. Ozdamar A, Aras C, Karacorlu M (2003) Suprachoroidal seton implantation in refractory glaucoma: a novel surgical technique. J Glaucoma 12:354–9

    Article  PubMed  Google Scholar 

  36. Schlote T, Derse M, Rassmann K, Nicaeus T, Dietz K, Thiel H-J (2001) Efficacy and safety of contact transscleral diode laser cyclophotocoagulation for advanced glaucoma. J Glaucoma 10:294–301

    Article  PubMed  CAS  Google Scholar 

  37. Schlote T, Ziemssen F, Bartz-Schmidt KU (2006) Pars plana modified Ahmed Glaucoma Valve for treatment of refractory glaucoma: A pilot study. Graefes Arch Exp Clin Ophthalmol 244(3):336–41

    Article  Google Scholar 

  38. Seitz B, Gruterich M, Cursiefen C, Kruse FE (2005) Konservative und chirurgische Behandlung der neurotrophen Keratopathie. Ophthalmologe 102:15–26

    Article  PubMed  CAS  Google Scholar 

  39. Sha-Desai SD, Tyers AG, Manners RM (2000) Painful blind eye: efficacy of enucleation and evisceration in resolving ocular pain. Br J Ophthalmol 84:437–8

    Article  Google Scholar 

  40. Sihota R, Sandramouli S, Sood NN (1991) A prospective evaluation of anterior retinal cryoablation in neovascular glaucoma. Ophthalmic Surg 22:256–9

    PubMed  CAS  Google Scholar 

  41. Sivagnavel V, Ortiz-Hurtado A, Williamson TH (2005) Diode laser trans-scleral cyclophotocoagulation in the management of glaucoma in patients with long-term intravitreal silicone oil. Eye 19:253–7

    Article  Google Scholar 

  42. Tolentino MJ, Miller JW, Gragoudas ES, Chatzistefanou K, Ferrara N, Adamis AP (1996) Vascular endothelial growth factor is sufficient to produce iris neovascularisation and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol 114:964–70

    PubMed  CAS  Google Scholar 

  43. Tripathi RC, Li J, Tripathi BJ, Chalam KV, Adamis AP (1998) Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology 105:232–7

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Augenzentrum der Klinik Pallas, Louis-Giroud-Strasse 20, 4600, Olten, Switzerland

    Torsten Schlote MD, PhD

  2. Department of Ophthalmology, University of Tübingen, Schleichstr. 12-16, 72076, Tübingen, Germany

    Karl-Ulrich Bartz-Schmidt MD

Authors
  1. Torsten Schlote MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karl-Ulrich Bartz-Schmidt MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Ophthalmology, University of Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany

    Antonia M. Joussen MD, PhD (Professor of Ophthalmology) (Professor of Ophthalmology)

  2. Department of Ophthalmology, Penn State College of Medicine, 500 University, Drive Box 850, Hershey, PA, 17033, USA

    Thomas W. Gardner MD, MS (Professor of Ophthalmology) (Professor of Ophthalmology)

  3. Department of Vitreoretinal Surgery, Center for Ophthalmology, University of Cologne, Joseph-Stelzmann-Straße 9, 50931, Cologne, Germany

    Bernd Kirchhof MD (Professor of Ophthalmology) (Professor of Ophthalmology)

  4. Doheny Eye Institute, University of Southern California, 1450 San Pablo Street, Los Angeles, CA, 90033, USA

    Stephen J. Ryan MD (Professor of Ophthalmology) (Professor of Ophthalmology)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schlote, T., Bartz-Schmidt, KU. (2007). Treatment of Rubeotic Secondary Glaucoma. In: Joussen, A.M., Gardner, T.W., Kirchhof, B., Ryan, S.J. (eds) Retinal Vascular Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-29542-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-29542-6_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-29541-9

  • Online ISBN: 978-3-540-29542-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation